MedTrace Logo

Follow-Up of Ureteral Stones ≤4 mm

NCT07176026 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1600

Last updated 2025-09-16

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the proportion of ureteral stones ≤4 mm that pass spontaneously within 4 and 8 weeks and assess if pain, blood test (S-creatinine), stone size, stone location and hydronephrosis can predict stone passage. The participants will be asked to fill in a questionare regarding symptoms, give a blood test and undergo a follow-up computed tomography.

Conditions

  • Kidney Stone

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Magnus Wagenius, PhD · University of Lund

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2027-01-01
Completion
2027-01-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07176026 on ClinicalTrials.gov